Can a doctor's referral to an exercise coach get people moving?
NCT ID NCT04947787
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program where doctors refer inactive people with chronic diseases (like diabetes, heart disease, or obesity) to an exercise professional for personalized counseling. The goal was to see if this referral scheme helps people become more active compared to just getting brief advice from their doctor. The study involved 168 participants in Germany and tracked their physical activity and health over 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- physical activity referral scheme (PARS)
- What this could lead to
- If successful, this could provide a model for doctors to refer patients with chronic diseases to exercise professionals, potentially improving health and activity levels.
- What could go wrong
- This is a completed, small study (168 participants) in one German region, so results may not apply broadly. The intervention is behavioral, so individual adherence and long-term effects are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
168 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years and older; living in the region of Erlangen-Nürnberg-Fürth, Germany; * At least one of the following existing non-communicable diseases (controlled type 2 diabetes mellitus; cardiovascular diseases; obesity (BMI ≥ 30 kg/m2); arthrosis in knee and/or hip); * Not meeting German PA recommendations (less than 150 minutes/week of moderate-intensity aerobic activity or less than 75 minutes/week of vigorous-intensity aerobic activity or any other equivalent combination); * The person can safely participate in physical activities based on general practitioners' clinical judgment. Exclusion Criteria: * The person plans to leave the region of Erlangen-Nürnberg-Fürth during the study period; * The person participating in another study with similar content; * The person is or plans to be absent for more than four weeks during the 12-week-intervention period; * Person has cognitive impairments that prevent an effective communication with the general practitioner and the therapist; * Persons with mental illness such as psychotic, substance abuse, mood, personality disorders; * Unstable clinical situation or serious health impairments that prevent from undertaking physical activity safely (e.g., acute myocardial infarction, unstable angina pectoris, fever, terminal tumor diseases
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthrosis of hip are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Friedrich-Alexander-University Erlangen-Nürnberg
Erlangen, 91058, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill takes aim at stubborn blood sugar
- Custom knee guides put to the test in obese patients
- Gene therapy shots aim to save legs from amputation in diabetes
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Can a nurse and a neighbor help tame chronic disease?